This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gaziev J, Lucarelli G . Hematopoietic stem cell transplantation for thalassemia. Curr Stem Cell Res Ther 2011; 6: 162–169.
La Nasa G, Littera R, Locatelli F, Giardini C, Ventrella A, Mulargia M et al. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients. Biol Blood Marrow Transplant 2007; 13: 1358–1368.
Mathews V, Savani BN . Conditioning regimens in allo-SCT for thalassemia major. Bone Marrow Transplant 2014; 49: 607–610.
Leplege A, Hunt S . The problem of quality of life in medicine. JAMA 1997; 278: 47–50.
Caocci G, Pisu S, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant 2006; 37: 165–169.
Cheuk DK, Mok AS, Lee AC, Chiang AK, Ha SY, Lau YL et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant 2008; 42: 319–327.
Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E et al. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2011; 17: 861–866.
Uygun V, Tayfun F, Akcan M, Karasu GT, Kupesiz A, Hazar V et al. Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients. Pediatr Hematol Oncol 2012; 29: 461–471.
Di Bartolomeo P, Santarone S, Di Bartolomeo E, Olioso P, Bavaro P, Papalinetti G et al. Long-term results of survival in patients with thalassemia major treated with bone marrow transplantation. Am J Hematol 2008; 83: 528–530.
La Nasa G, Caocci G, Efficace F, Dessì C, Vacca A, Piras E et al. Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood 2013; 122: 2262–2270.
Javanbakht M, Keshtkaran A, Shabaninejad H, Karami H, Zakerinia M, Delavari S . Comparison of blood transfusion plus chelation therapy and bone marrow transplantation in patients with β-thalassemia: application of SF-36, EQ-5D, and visual analogue scale measures. Int J Health Policy Manag 2015; 4: 733–740.
Ware JE, Kosinski M, Keller SD . SF-36 Physical and Mental Health Summary Scales: a User's Manual. The Health Institute: Boston, MA, USA, 1994.
Acknowledgements
We are grateful to Anna Maria Koopmans and Samantha Pinna for professional assistance in writing the manuscript.
Author contributions
GLN and GC designed and coordinated the study, interpreted data and wrote the first draft; PR coordinated data analyses; and AV, EP, VS, CD and MM recruited patients and administered and analyzed survey instruments.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Caocci, G., Vacca, A., Piras, E. et al. Return to normal life after hematopoietic stem cell transplantation for thalassemia: a study of patients transplanted from matched sibling donors. Bone Marrow Transplant 51, 1640–1641 (2016). https://doi.org/10.1038/bmt.2016.243
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2016.243
This article is cited by
-
Long-term health-related quality of life in patients with β-thalassemia after unrelated hematopoietic stem cell transplantation
Bone Marrow Transplantation (2022)
-
Health-related quality of life (HRQoL) in beta-thalassemia major (β-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis
Quality of Life Research (2019)